Human Anti-LTA scFv-Fc Chimera (VS-0425-FY147)
CAT#: VS-0425-FY147
Anti-LTA scFv-FC specifically binds to lipoteichoic acid (LTA), a component of the bacterial cell wall. This scFv-FC format aims to neutralize LTA's effects, reducing inflammatory responses associated with bacterial infections. The Fc region extends the half-life and can facilitate mechanisms like antibody-dependent cellular cytotoxicity (ADCC), making it a candidate for therapeutic use in infectious diseases.



Specifications
- Host Species
- Human
- Type
- Human IgG1, scFv-Fc
- Specificity
- Human LTA
- Species Reactivity
- Human
- Applications
- Neutralization
- Related Disease
- Psoriatic Arthritis and Leprosy 4
Product Property
- Purity
- >95% as determined by SDS-PAGE
- Concentration
- Please refer to the vial label for the specific concentration.
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
- Shipping
- Ice packs
Applications
- Application Notes
- The optimal dilution concentration is determined by the experiment.
Target
- Alternative Names
- LT; LTA; TNF-B; TNFSF1; Tumor Necrosis Factor Ligand Superfamily Member 1; Lymphotoxin Alpha
- Long Name
- Lymphotoxin Alpha
- Function
- Lipoteichoic acid (LTA) is a major surface component of Gram-positive bacteria, acting as a crucial structural molecule for cell wall integrity, growth, and division. Anchored in the bacterial membrane, it extends through the peptidoglycan layer.
Beyond its structural role, LTA is a potent modulator of the host immune system. It acts as a pathogen-associated molecular pattern (PAMP) recognized by pattern recognition receptors like Toll-like receptor 2 (TLR2) on immune cells. This recognition triggers signaling pathways leading to the release of pro-inflammatory cytokines, chemokines, and other immune mediators, playing a vital role in the initial response to Gram-positive bacterial infections. However, excessive LTA stimulation can also contribute to inflammation and tissue damage. The specific immune responses elicited by LTA can vary depending on its structural variations across different bacterial species.
Customer Review
There are currently no Customer reviews or questions for VS-0425-FY147. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Related Signaling Pathways
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
See other products for "LTA"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-2017-sdAb | Recombinant Anti-LTA VHH Single Domain Antibody | WB, ICC, ChiP, FA, ELISA | Llama VHH |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-071 | Anti-Human TNF beta Recombinant Antibody (TAB-071) | Neut, ELISA, IF, IP, FuncS, FC, ICC | IgG1 - kappa |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-266 | Human Anti-LTA Recombinant Antibody | WB, IHC, FuncS | Human IgG |
MRO-0943-CN | Recombinant Mouse Anti-LTA Monoclonal Antibody (C2-F2) | WB | Mouse IgG2b |
MRO-0944-CN | Recombinant Mouse Anti-LTA Monoclonal Antibody (6-C10-10) | WB | Mouse IgG1 |
MRO-2019-CN | Rabbit Anti-LTA Polyclonal Antibody (MRO-2019-CN) | WB | Rabbit IgG |
MRO-2020-CN | Rabbit Anti-LTA Polyclonal Antibody (MRO-2020-CN) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-275CQ-S(P) | Human Anti-LTA Recombinant Antibody; scFv Fragment (TAB-275CQ-S(P)) | ELISA, FC, WB | Mouse scFv |
TAB-275CQ-F(E) | Human Anti-LTA Recombinant Antibody; Fab Fragment (TAB-275CQ-F(E)) | ELISA, FC, WB | Chimeric (mouse/human) Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1702CQ | Recombinant Mouse Anti-LTA Antibody (359-238-8) | ELISA(Cap), ELISpot, Neut | IgG1, κ |
NEUT-1703CQ | Recombinant Human Anti-LTA Antibody (NEUT-1703CQ) | Neut, ELISA, FC | IgG1, κ |
NEUT-1704CQ | Recombinant Mouse Anti-LTA Antibody (CBL411) | ICC, Neut | IgG1 |
NEUT-1705CQ | Recombinant Mouse Anti-LTA Antibody (CBL412) | ELISA(Cap), Neut | IgG2a |
NEUT-1706CQ | Recombinant Mouse Anti-LTA Antibody (MM0575-7U9) | Neut, IHC, IHC-P | IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-2097 | Hi-Affi™ Recombinant Rabbit Anti-LTA Monoclonal Antibody (DS2097AB) | WB | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0209-YC-S(P) | Human Anti-LTA Recombinant Antibody (clone ch2C8); scFv Fragment | ELISA, FC, Block | Mouse scFv |
HPAB-0210-YC-S(P) | Human Anti-LTA Recombinant Antibody (clone ch3F12); scFv Fragment | ELISA, FC, Block | Mouse scFv |
HPAB-0211-YC-S(P) | Human Anti-LTA Recombinant Antibody (clone 2C8.v7); scFv Fragment | ELISA, FC, Block | Humanized scFv |
HPAB-0212-YC-S(P) | Human Anti-LTA Recombinant Antibody (clone 3F12.v5); scFv Fragment | ELISA, FC, Block | Humanized scFv |
HPAB-2080-FY-S(P) | Mouse Anti-LTA Recombinant Antibody (clone 96-110); scFv Fragment | ELISA | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0209-YC-F(E) | Human Anti-LTA Recombinant Antibody (clone ch2C8); Fab Fragment | ELISA, FC, Block | Human Fab |
HPAB-0210-YC-F(E) | Human Anti-LTA Recombinant Antibody (clone ch3F12); Fab Fragment | ELISA, FC, Block | Human Fab |
HPAB-0211-YC-F(E) | Human Anti-LTA Recombinant Antibody (clone 2C8.v7); Fab Fragment | ELISA, FC, Block | Humanized Fab |
HPAB-0212-YC-F(E) | Human Anti-LTA Recombinant Antibody (clone 3F12.v5); Fab Fragment | ELISA, FC, Block | Humanized Fab |
HPAB-2080-FY-F(E) | Mouse Anti-LTA Recombinant Antibody (clone 96-110); Fab Fragment | ELISA | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-071 | Afuco™ Anti-LTA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-071) | Neut, ELISA, IF, IP, FuncS, FC | ADCC enhanced antibody |
Popular Products
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA
Application: FuncS, Inhib, IP, ELISA
Application: WB, ELISA, FC, IHC, IP
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, WB
Application: ELISA, Neut, FuncS
Application: ELISA, WB, IF, FC, IP
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.